Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter and full-year ended Dec. 31, 2024.

Jose Altuve seems like an obvious choice, but if Carlos Beltrán is enshrined, would he choose where he got a ring or where he ...

ZUG, Switzerland and BOSTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...

VergeIO, a leader in ultraconverged infrastructure (UCI), recorded another record-breaking quarter with key wins in new ...

After winning the Super Bowl in New Orleans, here are the top players the Eagles should pursue via trade in 2025.

The Dali disaster did not affect the Britannia P&I Club’s decision to push for a 7.5% increase in premiums for 2025, the ...

Company delivers 96th consecutive quarter of topline growth Fourth quarter 2024 revenue grew 18% and recurring revenue grew 19% from the fourth quarter of 2023 MINNEAPOLIS, Feb. 10, 2025 (GLOBE NEWSWI ...

James Greenfield vividly remembers his first week running Koto. His friend, the artist Mr Bingo, had offered them a desk in the corner of his east London studio, where they installed two dining ...

As federal employees launched protests of entrepreneur Elon Musk’s disruption of federal agencies last week, the Office of ...

Revenue for the fourth quarter and full year 2024 was $47.5 million and $179.0 million, respectively. The MRD business, which contributed 85% of revenue in the fourth quarter and 81% of revenue in the ...

We ended 2024 with fourth quarter revenues of $2.7 billion, driven by strong leisure holiday travel. Net loss was nearly $2 billion, and Adjusted EBITDA 1 was a loss of $101 million. Full year ...

Myles Garrett dropped a bomb at the beginning of Super Bowl week last Monday. He publicly requested a trade from the ...